XML 23 R7.htm IDEA: XBRL DOCUMENT v3.23.4Close
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Oct. 31, 2023
Oct. 31, 2022
Oct. 31, 2021
Cash flow provided by operating activities:      
Net income $ 1,372,071 $ 1,286,500 $ 833,627
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 76,473 76,816 76,250
Stock-based compensation 24,805 21,095 23,187
Income from unconsolidated entities (50,098) (23,723) (74,035)
Distributions of earnings from unconsolidated entities 88,393 32,316 83,118
Deferred tax provision 36,239 (96,680) 11,815
Impairment charges and write-offs 69,537 39,541 26,535
(Gain) loss on sale of assets (416) 576 (38,706)
Other 3,181 3,781 (406)
Expenses related to early retirement of debt 0 0 35,211
Changes in operating assets and liabilities:      
Inventory (22,212) (618,829) (196,227)
Origination of mortgage loans (1,602,700) (2,035,637) (2,178,468)
Sale of mortgage loans 1,681,610 2,086,358 2,159,827
Receivables, prepaid expenses, and other assets (135,924) (95,018) 135,806
Current income taxes – net (162,570) 160,500 25,131
Customer deposits – net (88,285) (3,279) 165,637
Accounts payable and accrued expenses (23,674) 152,499 214,825
Net cash provided by operating activities 1,266,430 986,816 1,303,127 Close
Cash flow used in investing activities:      
Purchase of property, construction, and office equipment – net (72,961) (71,726) (66,878)
Investments in unconsolidated entities (216,438) (226,724) (221,932)
Return of investments in unconsolidated entities 112,749 116,769 203,504
Proceeds from the sale of assets, including ownership interests in unconsolidated entities 26,049 28,309 80,418
Other 0 196 652
Net cash used in investing activities (150,601) (153,176) (4,236) Close
Cash flow used in financing activities:      
Proceeds from loans payable 3,079,142 4,304,635 3,158,033
Debt issuance costs (5,365) 0 0
Principal payments of loans payable (3,239,418) (4,356,185) (3,425,065)
Redemption of senior notes (400,000) (409,856) (294,168)
Proceeds (payments) related to stock-based benefit plans – net 48,269 (690) 10,487
Purchase of treasury stock (561,595) (542,739) (378,256)
Dividends paid (91,082) (88,901) (76,623)
Receipts (payments) related to noncontrolling interest – net 11 (25,766) (5,491)
Net cash used in financing activities (1,170,038) (1,119,502) (1,011,083) Close
Net (decrease) increase in cash, cash equivalents, and restricted cash (54,209) (285,862) 287,808 Close
Cash, cash equivalents, and restricted cash, beginning of period 1,398,550 1,684,412 1,396,604
Cash, cash equivalents, and restricted cash, end of period $ 1,344,341 $ 1,398,550 $ 1,684,412